IT8025200A0 - Solvati di cefalosporine e relativo procedimento di preparazione. - Google Patents

Solvati di cefalosporine e relativo procedimento di preparazione.

Info

Publication number
IT8025200A0
IT8025200A0 IT8025200A IT2520080A IT8025200A0 IT 8025200 A0 IT8025200 A0 IT 8025200A0 IT 8025200 A IT8025200 A IT 8025200A IT 2520080 A IT2520080 A IT 2520080A IT 8025200 A0 IT8025200 A0 IT 8025200A0
Authority
IT
Italy
Prior art keywords
preparation procedure
related preparation
cephalosporin
solvates
cephalosporin solvates
Prior art date
Application number
IT8025200A
Other languages
English (en)
Other versions
IT1132926B (it
Inventor
Billy Grinnel Jackson
Donna A Nezich Gardner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IT8025200A0 publication Critical patent/IT8025200A0/it
Application granted granted Critical
Publication of IT1132926B publication Critical patent/IT1132926B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/12—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT25200/80A 1979-10-09 1980-10-08 Solvati di cefalosporine e relativo procedimento di preparazione IT1132926B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/082,822 US4252951A (en) 1979-10-09 1979-10-09 Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid

Publications (2)

Publication Number Publication Date
IT8025200A0 true IT8025200A0 (it) 1980-10-08
IT1132926B IT1132926B (it) 1986-07-09

Family

ID=22173679

Family Applications (1)

Application Number Title Priority Date Filing Date
IT25200/80A IT1132926B (it) 1979-10-09 1980-10-08 Solvati di cefalosporine e relativo procedimento di preparazione

Country Status (27)

Country Link
US (1) US4252951A (it)
EP (1) EP0027050B1 (it)
JP (1) JPS5661388A (it)
KR (1) KR840000866B1 (it)
AT (1) AT369008B (it)
AU (1) AU6306180A (it)
BE (1) BE885569A (it)
CA (1) CA1146539A (it)
CH (1) CH647523A5 (it)
CS (1) CS215142B2 (it)
DD (1) DD153375A5 (it)
DE (1) DE3065181D1 (it)
DK (1) DK424680A (it)
ES (1) ES8201166A1 (it)
FI (1) FI803200L (it)
FR (1) FR2467211A1 (it)
GB (1) GB2059966B (it)
GR (1) GR70219B (it)
HU (1) HU183230B (it)
IE (1) IE50390B1 (it)
IL (1) IL61227A (it)
IT (1) IT1132926B (it)
PH (1) PH15023A (it)
PT (1) PT71886B (it)
RO (1) RO80664B (it)
YU (1) YU256480A (it)
ZA (1) ZA806192B (it)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS588086A (ja) * 1981-07-07 1983-01-18 Takeda Chem Ind Ltd セフアロスポリン溶媒和物およびその製造法
JPH07116200B2 (ja) * 1985-09-20 1995-12-13 富山化学工業株式会社 セファロスポリンの製造方法
JPH08831B2 (ja) * 1985-09-20 1996-01-10 富山化学工業株式会社 セファロスポリンの精製法
PL350924A1 (en) * 1999-04-06 2003-02-10 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
WO2001017968A1 (fr) * 1999-09-02 2001-03-15 Shionogi & Co., Ltd. Inhibiteur d'integrase contenant des derives heterocycliques aromatiques
CA2284459C (en) * 1999-10-04 2012-12-11 Neokimia Inc. Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
EP1246792B1 (en) * 2000-01-13 2014-08-13 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
KR100904284B1 (ko) * 2001-03-08 2009-06-25 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 항-감염제로서의 표면적 친양쪽성 중합체
JP2005527467A (ja) * 2001-08-29 2005-09-15 ネオーズ テクノロジーズ， インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
JP4571497B2 (ja) * 2002-09-19 2010-10-27 杏林製薬株式会社 アミノアルコール誘導体とその付加塩及び免疫抑制剤
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
EP2471527A3 (en) * 2003-03-17 2012-12-12 The Trustees Of The University Of Pennsylvania Facially amphiphillc polymers and oligomers and uses thereof
US7321065B2 (en) * 2003-04-18 2008-01-22 The Regents Of The University Of California Thyronamine derivatives and analogs and methods of use thereof
US20050203184A1 (en) 2003-09-10 2005-09-15 Petasis Nicos A. Benzo lipoxin analogues
CA2554163A1 (en) * 2004-01-23 2005-08-11 The Trustees Of The University Of Pennsylvania Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof
ZA200609924B (en) * 2004-05-06 2008-12-31 Univ California Substituted enaminones, their derivatives and uses thereof
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
EP2301349A2 (en) * 2005-02-25 2011-03-30 The Trustees of The University of Pennsylvania Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
EP2418191A1 (en) * 2005-02-28 2012-02-15 Meiji Co., Ltd. Long-chain trimethoxyphenylalkanol derivatives, and pharmaceuticals comprising the same
BRPI0614805A2 (pt) * 2005-08-10 2011-04-12 Univ Johns Hopkins poliaminas úteis como produtos terapêuticos antiparasìticos e anticáncer e como inibidores de demetilase lisina-especìficos
MX2008001976A (es) * 2005-08-15 2008-03-25 Boehringer Ingelheim Int Procedimiento para la preparacion de betamimeticos.
RU2008120850A (ru) * 2005-10-28 2009-12-10 Айрм Ллк (Bm) Соединения и композиции в качестве ингибиторов протеинкиназ
WO2007063286A2 (en) * 2005-11-29 2007-06-07 Hammersmith Imanet Limited Amidine derivatives for in vivo imaging
ES2288107B1 (es) * 2006-01-27 2008-11-01 Fundacion Imabis Instituto Mediterraneo Para El Avance De La Biotecnologia Y La Investigacion Sanita Derivados aciclicos saturados e insaturados de cadena larga de sulfamidas como activadores especificos de receptores ppar-alfa.
FR2902996B1 (fr) * 2006-07-03 2008-09-26 Oreal Compositions cosmetiques associant un derive c-glycoside et un derive n-acylaminoamide
FR2902999B1 (fr) * 2006-07-03 2012-09-28 Oreal Utilisation de derives c-glycoside a titre d'actif prodesquamant
FR2903004B1 (fr) * 2006-07-03 2009-07-10 Oreal Utilisation en cosmetique d'un derive c-glycoside en association avec de l'acide ascorbique
US20090075935A1 (en) * 2006-07-03 2009-03-19 L'oreal Composition comprising at least one c-glycoside derivative and at least one hyaluronic acid and its cosmetic use
ES2375761T3 (es) * 2006-12-14 2012-03-06 Teva Pharmaceutical Industries Ltd. Base de rasagilina cristalina sólida.
GB2462235B8 (en) 2007-05-11 2013-03-27 Biotechnology Res Corp Ltd Receptor modulators exhibiting neuroprotective andmemory enhancing activities
US7696383B2 (en) * 2007-06-26 2010-04-13 Solvay Pharmaceuticals B.V. N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
FR2920000B1 (fr) * 2007-08-13 2010-01-29 Oreal Composition cosmetique ou pharmaceutique contenant de l'acide hyaluronique, et procede cosmetique pour diminuer les signes du vieilissement
ATE543799T1 (de) * 2007-10-19 2012-02-15 Janssen Pharmaceutica Nv Piperidinyl- und piperazinylmodulatoren von g- sekretase
BRPI0818773A2 (pt) * 2007-10-19 2015-04-14 Janssen Pharmaceutica Nv Moduladores de gama-secretase ligados a carbono
WO2009052350A1 (en) * 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Amine linked modulators of y-secretase
EP2093207A1 (en) * 2008-02-06 2009-08-26 Julius-Maximilians-Universität Würzburg Antiinfective and antitumoral compounds isolated from tropical lianas
US8063249B1 (en) * 2008-04-25 2011-11-22 Olema Pharmaceuticals, Inc. Substituted triphenyl butenes
WO2010017328A2 (en) * 2008-08-06 2010-02-11 Rgo Biosciences Llc Cyclodextrin conjugates
EA201100654A1 (ru) 2008-10-22 2012-01-30 Акусела, Инк. Соединения для лечения офтальмологических заболеваний и расстройств
FR2940610B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides avec des derives c-glycosides et son utilisation en cosmetique
WO2010111530A1 (en) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipids as treatment for disease
PE20120907A1 (es) * 2009-05-14 2012-08-18 Millennium Pharm Inc Sal de clorhidrato de ((1s,2s,4r)-4-{4-[(1s)-2,3-dihidro-1h-inden-1-ilamino]-7h-pirrolo[2,3-d]pirimidin-7-il}-2-hidroxiciclopentil)metilsulfamato
WO2010138828A2 (en) * 2009-05-29 2010-12-02 Abbott Laboratories Potassium channel modulators
US8288592B2 (en) * 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
US8609674B2 (en) 2010-11-16 2013-12-17 Abbvie Inc. Potassium channel modulators
KR101991980B1 (ko) * 2011-09-06 2019-06-21 큐알엔에이, 인크. 소형 분자로 전압-개폐된 나트륨 채널 (SCNxA)의 알파 아단위에 관련된 질환의 치료
US8377946B1 (en) 2011-12-30 2013-02-19 Pharmacyclics, Inc. Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925372A (en) * 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid

Also Published As

Publication number Publication date
ES495753A0 (es) 1981-12-01
RO80664A (ro) 1983-02-15
CA1146539A (en) 1983-05-17
IE802086L (en) 1981-04-09
GB2059966A (en) 1981-04-29
BE885569A (fr) 1981-04-08
FI803200L (fi) 1981-04-10
FR2467211B1 (it) 1983-06-10
KR830004314A (ko) 1983-07-09
DD153375A5 (de) 1982-01-06
AU6306180A (en) 1981-04-16
YU256480A (en) 1983-02-28
GB2059966B (en) 1983-09-01
IL61227A0 (en) 1980-12-31
FR2467211A1 (fr) 1981-04-17
HU183230B (en) 1984-04-28
EP0027050A1 (en) 1981-04-15
GR70219B (it) 1982-08-31
AT369008B (de) 1982-11-25
US4252951A (en) 1981-02-24
IE50390B1 (en) 1986-04-16
IT1132926B (it) 1986-07-09
ATA498080A (de) 1982-04-15
DE3065181D1 (en) 1983-11-10
RO80664B (ro) 1983-02-28
CH647523A5 (fr) 1985-01-31
JPS5661388A (en) 1981-05-26
DK424680A (da) 1981-04-10
IL61227A (en) 1983-07-31
KR840000866B1 (ko) 1984-06-20
PT71886B (en) 1981-08-13
PH15023A (en) 1982-05-13
PT71886A (en) 1980-11-01
CS215142B2 (en) 1982-07-30
ZA806192B (en) 1982-05-26
ES8201166A1 (es) 1981-12-01
EP0027050B1 (en) 1983-10-05

Similar Documents

Publication Publication Date Title
IT8025200A0 (it) Solvati di cefalosporine e relativo procedimento di preparazione.
IT8024229A0 (it) Composizioni vulcanizzabili erelativo procedimento.
IT1209179B (it) Procedimento di misura.
SE8000105L (sv) 2-penemforeningar samt forfarande for framstellning derav
ES497517A0 (es) Procedimiento de preparacion de nuevos iminoacidos y de sus derivados.
NL930029I2 (nl) Enzymederivaten en bereiding daarvan.
NL180632C (nl) Antitranspiratiepreparaat.
IT1131038B (it) Filatoio lungo
IT1144006B (it) Pentaidrato di cefalosporina composizioni che lo contengono e relativo procedimento di preparazione ed applicazione
DK36780A (da) Haerdelige materialer
NL188592C (nl) Scharnier.
IT8022242A0 (it) Cefalosporine e loro preparazione.
IT8049782A0 (it) Biscloridrato di cefalosporina, composizioni che lo contengono e relativo procedimento di preparazione ed applicazione
IT8024074A0 (it) Giunto magnetico.
DK467680A (da) Hoerevaern
IT1114908B (it) Eterofulvaleni sostituiti e relativo procedimento di preparazione
IT8022986A0 (it) Preparazione deldiidrodimetil-7-idrossi-benzofurano .
SE7808066L (sv) Cefalosporiner och forfarande for framstellning derav
IT8083454A0 (it) Harzburgite e procedimento per lapreparazione della stessa.
IT8025989A0 (it) Copiatura. procedimento ed apparecchiatura di
IT8020473A0 (it) Fenilmorfani intermedi eprocedimento di preparazione.
DK19780A (da) Cephalosporinforbindelser
IT8053608V0 (it) Coppiglia di bloccaggio
ES488972A0 (es) Procedimiento de preparar antibioticos sisomicinicos.
DK147129C (da) Fremgangsmaade til fremstilling af depsipeptid-antibiotika neoviridogrisein i, ii og iii samt eventuelt viridogrisein og griseoviridin